Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

International trends in COPD mortality, 1995–2017

Joannie Lortet-Tieulent, Isabelle Soerjomataram, José Luis López-Campos, Julio Ancochea, Jan Willem Coebergh, Joan B. Soriano
European Respiratory Journal 2019 54: 1901791; DOI: 10.1183/13993003.01791-2019
Joannie Lortet-Tieulent
1Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joannie Lortet-Tieulent
  • For correspondence: tieulentj@fellows.iarc.fr
Isabelle Soerjomataram
1Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Isabelle Soerjomataram
José Luis López-Campos
2Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain
3Unidad Médico-Quirúrgica de Enfermedades Respiratorias, Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocío/Universidad de Sevilla, Seville, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for José Luis López-Campos
Julio Ancochea
4Instituto de Investigación, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan Willem Coebergh
5Dept of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jan Willem Coebergh
Joan B. Soriano
2Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain
4Instituto de Investigación, Hospital Universitario de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Joan B. Soriano
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Extract

Since 2016, chronic obstructive pulmonary disease (COPD) has been the third-leading cause of death worldwide, with an estimated 3 million deaths (5.3% of all deaths), but with large regional variations [1]. Observed data from high-income countries (HICs) [2–5] and modelled data in two global studies [6, 7] have reported declines in COPD mortality rates since the 1990s. Globally, since 2006, modelled COPD mortality rates decreased by 21% [8]. Yet, little is known about observed trends in COPD mortality in Latin America, and more recently in Oceania and Europe.

Abstract

In our international study over 1995–2017, COPD mortality rates declined in most countries. Yet, in females, they remained stable in North America and increased in six countries in Europe. The number of deaths increased or remained stable in most countries. http://bit.ly/2niUQ8d

Footnotes

  • Disclaimer: Where authors are identified as personnel of the International Agency for Research on Cancer/World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer/World Health Organization.

  • Conflict of interest: J. Lortet-Tieulent has nothing to disclose.

  • Conflict of interest: I. Soerjomataram has nothing to disclose.

  • Conflict of interest: J.L. López-Campos reports personal fees and non-financial support from AstraZeneca, CSL Behring and Ferrer, and grants, personal fees and non-financial support from Boehringer Ingelheim, Chiesi, Esteve, GebroPharma, GlaxoSmithKline, Grifols, Menarini, Novartis, Rovi and Teva, outside the submitted work.

  • Conflict of interest: J. Ancochea has nothing to disclose.

  • Conflict of interest: J.W. Coebergh has nothing to disclose.

  • Conflict of interest: J.B. Soriano participated in speaking activities, advisory committees and consultancies during the period 2014–2019 sponsored by: Almirall, AstraZeneca, Boehringer-Ingelheim, CHEST, Chiesi, ERS, GEBRO, Grifols, GSK, Linde, Lipopharma, Mundipharma, Novartis, Pfizer, RiRL, Rovi, Sandoz, SEPAR and Takeda. J.B. Soriano declares not receiving ever, directly or indirectly, funding from the tobacco industry or its affiliates.

  • Received September 6, 2018.
  • Accepted September 25, 2019.
  • Copyright ©ERS 2019
https://www.ersjournals.com/user-licence
View Full Text

ERS Members

myERS - ERS members : log in with your myERS username and password.

INDIVIDUALS

Log in Login as an individual user.

Forgot your username or password?

LIBRARY USERS

Log in through your institution

If your library has a subscription, you may already be logged in via your IP address. Otherwise you may be able to log in via one of the following routes.
You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.
If you think you should have access, please contact your librarian or email journals@ersnet.org

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top
View this article with LENS
Vol 54 Issue 6 Table of Contents
European Respiratory Journal: 54 (6)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
International trends in COPD mortality, 1995–2017
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
International trends in COPD mortality, 1995–2017
Joannie Lortet-Tieulent, Isabelle Soerjomataram, José Luis López-Campos, Julio Ancochea, Jan Willem Coebergh, Joan B. Soriano
European Respiratory Journal Dec 2019, 54 (6) 1901791; DOI: 10.1183/13993003.01791-2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
International trends in COPD mortality, 1995–2017
Joannie Lortet-Tieulent, Isabelle Soerjomataram, José Luis López-Campos, Julio Ancochea, Jan Willem Coebergh, Joan B. Soriano
European Respiratory Journal Dec 2019, 54 (6) 1901791; DOI: 10.1183/13993003.01791-2019
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Shareable PDF
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Asthma admissions during the COVID-19 pandemic
  • Challenges of nasal/pharyngeal swabs during the COVID-19 pandemic
  • Vitamin D status and seroconversion for COVID-19
Show more Agora

Research letters

  • Vitamin D status and seroconversion for COVID-19
  • Challenges of nasal/pharyngeal swabs during the COVID-19 pandemic
  • Supernormal lung function and risk of hospitalisations and mortality
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society